The Beauty Health Company Names Pedro Malha President and Chief Executive Officer
The Beauty Health Company (NASDAQ: SKIN) has appointed Pedro Malha as its new President and Chief Executive Officer, effective October 1, 2025. Malha, who brings over 20 years of experience in healthcare and medical devices, succeeds Marla Beck, who is stepping down but will remain in an advisory role.
Malha joins from Abbott Laboratories, where he served as Worldwide Division President and Corporate Officer leading the neuromodulation business. His prior experience includes senior leadership roles at Zimmer Biomet Holdings, Abbott, and Johnson & Johnson in Europe.
Under Beck's leadership, BeautyHealth underwent significant transformation, including strengthening its innovation pipeline, upgrading manufacturing and operations, improving margins, and maintaining Hydrafacial's position as a leading performance skin health brand.
Beauty Health Company (NASDAQ: SKIN) ha nominato Pedro Malha come nuovo Presidente e Amministratore Delegato, con effetto a partire dal 1 ottobre 2025. Malha, forte di oltre 20 anni di esperienza nel settore sanitario e nei dispositivi medici, succede a Marla Beck, che si dimetterà ma rimarrà in ruolo di consulente.
Malha arriva da Abbott Laboratories, dove ha ricoperto il ruolo di Worldwide Division President e Corporate Officer guidando la business neuromodulation. In passato ha ricoperto ruoli di alto livello presso Zimmer Biomet Holdings, Abbott e Johnson & Johnson in Europa.
Sotto la guida di Beck, BeautyHealth ha attraversato una significativa trasformazione, tra cui il rafforzamento del pipeline di innovazione, il miglioramento della produzione e delle operazioni, l’aumento dei margini e il mantenimento della posizione di Hydrafacial come brand leader nel campo della pelle ad alte prestazioni.
The Beauty Health Company (NASDAQ: SKIN) ha designado a Pedro Malha como su nuevo Presidente y Director Ejecutivo, con efecto a partir del 1 de octubre de 2025. Malha, con más de 20 años de experiencia en atención sanitaria y dispositivos médicos, sucede a Marla Beck, quien dimite pero permanecerá en un rol de asesoría.
Malha procede de Abbott Laboratories, donde se desempeñó como Worldwide Division President y Corporate Officer liderando el negocio de neuromodulación. Su experiencia previa incluye puestos de alta dirección en Zimmer Biomet Holdings, Abbott y Johnson & Johnson en Europa.
Bajo la dirección de Beck, BeautyHealth experimentó una transformación significativa, incluida la fortalecimiento del pipeline de innovación, la mejora de la fabricación y operaciones, la incremento de márgenes y el mantenimiento de Hydrafacial como una marca líder en salud de la piel de alto rendimiento.
Beauty Health Company (NASDAQ: SKIN)가 새 사장 겸 최고경영자로 Pedro Malha를 임명했으며, 발효일은 2025년 10월 1일입니다. 20년이 넘는 보건의료 및 의료기기 분야의 경험을 가진 Malha는 물러나는 Marla Beck를 계승하며 자문 역할로 남습니다.
Malha는 Abbott Laboratories에서 전 세계 부문 사장(Worldwide Division President) 및 기업 임원(Corporate Officer)으로 뉴로모듀에이션 사업을 이끌던 인물로 합류합니다. 그의 이전 경력으로 유럽 지역에서 Zimmer Biomet Holdings, Abbott, Johnson & Johnson의 고위 직책이 포함됩니다.
Beck의 리더십 아래 BeautyHealth는 혁신 파이프라인 강화, 제조 및 운영의 업그레이드, 마진 개선, Hydrafacial를 고성능 피부 건강 브랜드로서의 위치를 유지하는 등 대대적인 변화를 겪었습니다.
Beauty Health Company (NASDAQ: SKIN) a nommé Pedro Malha au poste de nouveau Président-directeur général, à compter du 1er octobre 2025. Malha, qui apporte plus de 20 ans d'expérience dans le secteur de la santé et des dispositifs médicaux, succède à Marla Beck, qui se retire mais restera dans un rôle de conseil.
Malha rejoint Abbott Laboratories, où il était Worldwide Division President et Corporate Officer, dirigeant le secteur de la neuromodulation. Son expérience précédente comprend des postes de direction chez Zimmer Biomet Holdings, Abbott et Johnson & Johnson en Europe.
Sous la direction de Beck, BeautyHealth a connu une transformation significative, notamment le renforcement du pipeline d'innovation, l'amélioration des procédés de fabrication et des opérations, l'amélioration des marges et le maintien de Hydrafacial en tant que marque leader dans le domaine de la peau performante.
Beauty Health Company (NASDAQ: SKIN) hat Pedro Malha zum neuen Präsidenten und Chief Executive Officer ernannt, mit Wirkung zum 1. Oktober 2025. Malha verfügt über mehr als 20 Jahre Erfahrung im Gesundheitswesen und in medizinischen Geräten und folgt auf Marla Beck, die zurücktritt, aber in einer beratenden Rolle bleibt.
Malha kommt von Abbott Laboratories, wo er als Worldwide Division President und Corporate Officer das Neuromodulations-Geschäft geleitet hat. Zuvor hatte er Führungspositionen bei Zimmer Biomet Holdings, Abbott und Johnson & Johnson in Europa inne.
Unter Becks Führung erlebte BeautyHealth eine bedeutende Transformation, einschließlich der Stärkung des Innovationspools, der Aufrüstung von Fertigung und Betrieb, der Margenverbesserung und der Aufrechterhaltung von Hydrafacial als führende Marke im Bereich leistungsstarke Hautgesundheit.
Beauty Health Company (NASDAQ: SKIN) عينت Pedro Malha كـرئيس تنفيذي جديد ومدير عام، اعتبارًا من 1 أكتوبر 2025. يملك مالها أكثر من 20 عامًا من الخبرة في الرعاية الصحية والأجهزة الطبية، وهو يعقِب Marla Beck الذي سيتنحى ولكنه سيبقى في دور استشاري.
ينضم مالها من Abbott Laboratories، حيث شغل منصب رئيس القسم العالمي ونائب تنفيذي يقود أعمال التحفيز العصبي. تشمل خبرته السابقة مناصب قيادية عليا في Zimmer Biomet Holdings، Abbott وJohnson & Johnson في أوروبا.
تحت قيادة Beck، شهدت BeautyHealth تحولًا كبيرًا، بما في ذلك تعزيز خط الابتكار، وترقية التصنيع والعمليات، وتحسين الهوامش، والحفاظ على Hydrafacial كعلامة رائدة في مجال صحة الجلد عالية الأداء.
Beauty Health Company (NASDAQ: SKIN) 已任命 Pedro Malha为新任总裁兼首席执行官，任命自 2025年10月1日起生效。Malha 在医疗保健和医疗器械领域拥有超过20年的经验，接任将辞任但将担任顾问角色的 Marla Beck。
Malha 将从 Abbott Laboratories 加入，该公司任全球事业部总裁及企业高管，领导神经调控业务。他的前任经历包括在欧洲的 Zimmer Biomet Holdings、Abbott 和 Johnson & Johnson 的高级领导职务。
在 Beck 的领导下，BeautyHealth 经历了重大转型，包括加强创新管线、升级制造与运营、改善利润率，以及保持 Hydrafacial 作为高性能皮肤健康品牌的领先地位。
- Appointment of experienced healthcare executive Pedro Malha with over 20 years of global industry experience
- Strong operational improvements under previous leadership including enhanced manufacturing and quality control
- Successful transformation period resulting in strengthened margins and return to profitability
- Robust pipeline of innovation and brand initiatives currently in development
- Leadership transition period could create temporary operational uncertainty
- Departure of CEO Marla Beck who successfully led company transformation
Insights
Pedro Malha's appointment as Beauty Health's CEO brings healthcare expertise to lead Hydrafacial's next growth phase after Beck's successful restructuring.
This executive transition at Beauty Health (SKIN) represents a strategic pivot as the company enters its next growth phase. Marla Beck's tenure focused on rebuilding fundamental business operations—revitalizing the innovation pipeline, upgrading manufacturing and quality control systems, and implementing cost structure improvements that restored profitability. These operational improvements were essential groundwork before pursuing aggressive growth.
Pedro Malha's selection signals the board's strategic direction. With over 20 years in healthcare and medical devices, including leadership at Abbott Laboratories, Zimmer Biomet, and Johnson & Johnson, Malha brings valuable experience navigating regulated markets and scaling medical technology businesses globally. His background aligns perfectly with Hydrafacial's positioning at the intersection of beauty and healthcare—a critical differentiation in the increasingly competitive aesthetics market.
The timing of this transition suggests Beauty Health has completed its restructuring phase and is now prepared for expansion. Beck's shift to an advisory role indicates a planned, orderly succession rather than an abrupt departure, which typically maintains operational continuity. Malha's experience leading Abbott's neuromodulation division particularly matters—it demonstrates expertise with subscription-based medical devices requiring provider partnerships, similar to Hydrafacial's business model.
This leadership change reflects Beauty Health's evolution from turnaround mode to growth execution, with emphasis on scaling its science-backed skin health platform while maintaining the operational discipline established during Beck's tenure.
Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1
Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth
LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role.
Brent Saunders, Chairman of the Board, stated, “Pedro is an accomplished leader with broad industry experience at leading multinational companies in the healthcare and medical device sectors. His ability to navigate complex global markets and build collaborative, high-performing teams makes him the right person to lead BeautyHealth into its next chapter. We are also grateful for Marla’s strong leadership during a pivotal period of transformation, which has left BeautyHealth well positioned for sustainable and profitable growth.”
During her tenure, Ms. Beck guided BeautyHealth through a period of significant change, reigniting the Company’s science-backed innovation pipeline, streamlining and upgrading manufacturing, quality control, and operations, and refining the cost structure to strengthen margins and return the Company to profitability. She also reinforced Hydrafacial’s dual commitment to both providers and consumers, ensuring it remains the gold standard in performance skin health.
Ms. Beck said: “I am incredibly proud of what we have accomplished together to strengthen BeautyHealth’s foundation and future. With the right team and strategy in place, I believe now is the right time to welcome a new CEO to lead the Company into its next phase of growth. BeautyHealth has a robust pipeline of innovation and bold brand initiatives currently underway, and I look forward to watching the Company continue to thrive under Pedro’s leadership.”
Mr. Malha joins BeautyHealth following a distinguished global career spanning more than two decades across the healthcare and medical device industries. He most recently served as Worldwide Division President and Corporate Officer of Abbott Laboratories, where he led the neuromodulation business. Prior to that, he held senior leadership roles overseeing multiple global business units at Zimmer Biomet Holdings, Abbott, and Johnson & Johnson in Europe, where he consistently delivered growth and operational excellence. He holds an MBA from Boston University and a Bachelor of Science from Bentley University.
“I am honored to join BeautyHealth and lead this exceptional Company into the future,” stated Mr. Malha. “Hydrafacial is a category-defining brand with unmatched potential at the intersection of beauty and health. I look forward to working alongside the Board, the leadership team, and our global community of providers to shape the future of skin health through continued science-backed innovation and operational excellence, while accelerating profitable growth and creating lasting value for stakeholders around the world.”
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn.
Contacts:
Hydrafacial Media Contact: press@beautyhealth.com
Investors: IR@beautyhealth.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6d01c322-0bb8-4a02-bb64-eba8c518ee54
FAQ
Who is the new CEO of Beauty Health Company (NASDAQ: SKIN)?
Why is Marla Beck stepping down as CEO of Beauty Health Company?
What is Pedro Malha's background and experience?
What improvements did Beauty Health Company make under Marla Beck's leadership?
When will Pedro Malha take over as CEO of Beauty Health Company (SKIN)?
